Explorer les evidences

10,8 odds_ratioThe summary odds ratio between non-autoimmune diabetes and SARS-CoV-2 infection risk was 10.8 (95% CI: 10.3–11.4) based on one study.

CamerounCOVID-19 · non-autoimmune diabetes mellituspublié 2021Scientific reportseurope_pmcdocument de 11 observationsDOI 10.1038/s41598-021-88598-6

69 patientsSixty-nine out of 80 COVID-19 positive patients (86.3%) had baseline cortisol ≤413.79 nmol/L, suggesting an insufficient response to stress.

CamerounCOVID-19publié 2020Baseline Serum Total Cortisol During the Primary Corona Virus Infection in the Beginning oeurope_pmcdocument de 12 observationsDOI 10.21203/rs.3.rs-78801/v1

The COVID-19 pandemic occurred in 2020.

CamerounCOVID-19observé 2020publié 2022Journal of public health in Africaeurope_pmcdocument de 9 observationsDOI 10.4081/jphia.2022.2195

22,2 %The in-hospital mortality among COVID-19 patients hospitalized at Laquintinie Douala hospital in Cameroon was 22.2%.

CamerounCOVID-19observé 2020publié 2022Travel medicine and infectious diseaseeurope_pmcdocument de 5 observations

18,6 %Overall age-standardized SARS-CoV-2 IgG seroprevalence in Yaoundé, Cameroon was 18.6% during January 27–February 6, 2021.

CamerounCOVID-19observé January 27–February 6, 2021publié 2022Emerging infectious diseasesOpenAlexdocument de 2 observationsDOI 10.3201/eid2806.212580

75 bpmA reduction of heart rate was observed between D0 and D7 (75±13 bpm versus 70±13 bpm, p = 0.02).

CamerounCOVID-19observé 2020publié 2020Electrocardiographic safety of daily Hydroxychloroquine 400mg plus Azithromycin 250mg as aeurope_pmcdocument de 6 observationsDOI 10.1101/2020.06.24.20139386

51,3 %Overall age-standardized SARS-CoV-2 IgG seroprevalence in Yaoundé, Cameroon was 51.3% during April 24–May 19, 2021.

CamerounCOVID-19observé April 24–May 19, 2021publié 2022Emerging infectious diseasesOpenAlexdocument de 2 observationsDOI 10.3201/eid2806.212580

No symptomatic arrhythmic events occurred during the treatment course.

CamerounCOVID-19observé 2020publié 2020Electrocardiographic safety of daily Hydroxychloroquine 400mg plus Azithromycin 250mg as aeurope_pmcdocument de 6 observationsDOI 10.1101/2020.06.24.20139386

429 msNo significant change from baseline (D0) of QTc was observed at D7 (429±27 ms at D0 versus 396±26 ms at D7; p=0.27).

CamerounCOVID-19observé 2020publié 2020Electrocardiographic safety of daily Hydroxychloroquine 400mg plus Azithromycin 250mg as aeurope_pmcdocument de 6 observationsDOI 10.1101/2020.06.24.20139386

5 %PCR-positivity was 5% at IUEs/INSAM-Yaounde.

CamerounCOVID-19observé November 2020 to July 2021publié 2023VirusesOpenAlexdocument de 12 observationsDOI 10.3390/v15020407

25,25 %PCR-positivity was 25.25% at UdM-Bangangte, 27.27% at ISSBA-Yaounde, and 5% at IUEs/INSAM-Yaounde.

CamerounCOVID-19observé November 2020 to July 2021publié 2023VirusesOpenAlexdocument de 12 observationsDOI 10.3390/v15020407

7 casesAmong the 80 COVID-19 positive patients, diabetes mellitus was present in 7 (8.8%).

CamerounCOVID-19 · diabète (non précisé)publié 2020Baseline Serum Total Cortisol During the Primary Corona Virus Infection in the Beginning oeurope_pmcdocument de 12 observationsDOI 10.21203/rs.3.rs-78801/v1

80,4 %At day 3, 74 out of 92 participants (80.4%) on doxycycline were asymptomatic.

CamerounCOVID-19publié 2021Doxycycline is a safe alternative to Hydroxychloroquine + Azithromycin to prevent clinicaleurope_pmcdocument de 8 observationsDOI 10.1101/2021.07.25.21260838

9 casesAmong the 80 COVID-19 positive patients, hypertension was present in 9 (11.3%), diabetes mellitus in 7 (8.8%), cardiovascular disease in 8 (10%), and obesity in 4 (5%).

CamerounCOVID-19 · hypertension artériellepublié 2020Baseline Serum Total Cortisol During the Primary Corona Virus Infection in the Beginning oeurope_pmcdocument de 12 observationsDOI 10.21203/rs.3.rs-78801/v1

65,2 %On day 10, 60 out of 92 participants (65.2%) assigned to doxycycline had a negative SARS-CoV-2 PCR test.

CamerounCOVID-19publié 2023Cureuseurope_pmcdocument de 7 observations

27,27 %PCR-positivity was 27.27% at ISSBA-Yaounde.

CamerounCOVID-19observé November 2020 to July 2021publié 2023VirusesOpenAlexdocument de 12 observationsDOI 10.3390/v15020407

75 casesAmong the 80 COVID-19 positive patients, respiratory symptoms were reported in 75 (93.7%).

CamerounCOVID-19publié 2020Baseline Serum Total Cortisol During the Primary Corona Virus Infection in the Beginning oeurope_pmcdocument de 12 observationsDOI 10.21203/rs.3.rs-78801/v1

95,7 %On day 10, 88 out of 92 participants (95.7%) on doxycycline were asymptomatic.

CamerounCOVID-19publié 2023Cureuseurope_pmcdocument de 7 observations

95 msQRS duration increased between D0 and D7 (95±10 ms versus 102±17 ms, p = 0.004).

CamerounCOVID-19observé 2020publié 2020Electrocardiographic safety of daily Hydroxychloroquine 400mg plus Azithromycin 250mg as aeurope_pmcdocument de 6 observationsDOI 10.1101/2020.06.24.20139386

4 casesAmong the 80 COVID-19 positive patients, obesity was present in 4 (5%).

CamerounCOVID-19 · obésitépublié 2020Baseline Serum Total Cortisol During the Primary Corona Virus Infection in the Beginning oeurope_pmcdocument de 12 observationsDOI 10.21203/rs.3.rs-78801/v1

At day 30, all participants were asymptomatic.

CamerounCOVID-19publié 2021Doxycycline is a safe alternative to Hydroxychloroquine + Azithromycin to prevent clinicaleurope_pmcdocument de 8 observationsDOI 10.1101/2021.07.25.21260838

10 patientsAmong the 80 COVID-19 positive patients, 10 (12.5%) received oxygen therapy.

CamerounCOVID-19publié 2020Baseline Serum Total Cortisol During the Primary Corona Virus Infection in the Beginning oeurope_pmcdocument de 12 observationsDOI 10.21203/rs.3.rs-78801/v1

70 casesAmong the 80 COVID-19 positive patients, the non-severe form was the most common, observed in 70 (87.5%).

CamerounCOVID-19publié 2020Baseline Serum Total Cortisol During the Primary Corona Virus Infection in the Beginning oeurope_pmcdocument de 12 observationsDOI 10.21203/rs.3.rs-78801/v1

97,9 %At day 10, 93 out of 95 participants (97.9%) on hydroxychloroquine-azithromycin were asymptomatic.

CamerounCOVID-19publié 2021Doxycycline is a safe alternative to Hydroxychloroquine + Azithromycin to prevent clinicaleurope_pmcdocument de 8 observationsDOI 10.1101/2021.07.25.21260838

On day 30, all participants were asymptomatic.

CamerounCOVID-19publié 2023Cureuseurope_pmcdocument de 7 observations